{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:32:59Z","timestamp":1788244379172,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd013024","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T00:00:00Z","timestamp":1558656000000}}],"reference-count":101,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013024.pub2","type":"journal-article","created":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T14:32:04Z","timestamp":1558708324000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Head-to-head oral prophylactic antibiotic therapy for chronic obstructive pulmonary disease"],"prefix":"10.1002","volume":"2019","author":[{"given":"Christopher JD","family":"Threapleton","sequence":"first","affiliation":[{"name":"St George's, University of London; Clinical Pharmacology; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Janjua","sequence":"additional","affiliation":[{"name":"St George's, University of London; Cochrane Airways, Population Health Research Institute; London UK SW17 0RE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Fortescue","sequence":"additional","affiliation":[{"name":"St George's, University of London; Cochrane Airways, Population Health Research Institute; London UK SW17 0RE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma H","family":"Baker","sequence":"additional","affiliation":[{"name":"St George's, University of London; Clinical Pharmacology; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,5,24]]},"reference":[{"key":"10.1002\/14651858.CD013024.pub2-BIB0001|cit1","first-page":"P4731","article-title":"Bacterial resistance induction with prophylactic antibiotics in COPD [Abstract]","volume":"44","author":"Brill","year":"2014","journal-title":"European Respiratory Journal"},{"issue":"10","key":"10.1002\/14651858.CD013024.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/thoraxjnl-2015-207194","article-title":"Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trial","volume":"70","author":"Brill","year":"2015","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0003|cit3","first-page":"A2874","article-title":"Effect of antibiotics on airway bacteria in patients with chronic obstructive pulmonary disease (Abstract)","volume":"189","author":"Brill","year":"2014","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0004|cit4","unstructured":"NCT01398072 Development of an optimal antibiotic regime for long-term therapy in stable chronic obstructive pulmonary disease (COPD) clinicaltrials.gov\/show\/NCT01398072"},{"issue":"1","key":"10.1002\/14651858.CD013024.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12952-015-0034-8","article-title":"A double-blind, randomised, placebo-controlled study of roxithromycin and doxycycline combination, roxithromycin alone, or matching placebo for 12 weeks in adults with frequent exacerbations of chronic obstructive pulmonary disease","volume":"14","author":"Shafuddin","year":"2015","journal-title":"Journal of Negative Results in Biomedicine"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0006|cit6","first-page":"44","article-title":"Infectious exacerbation of chronic obstructive pulmonary disease: prospects for high-dose levofloxacin therapy","volume":"91","author":"Astaf'ev","year":"2013","journal-title":"Klinicheskaia Meditsina"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0007|cit7","unstructured":"Blasi F Bonardi D Guffanti E Confalonieri M Tarsia P Alberti S Azithromycin prophylaxis in COPD patients with tracheostomy Proceedings of the American Thoracic Society 2006 A21"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0008|cit8","unstructured":"Braendli O Keller R Fruehauf B Matter JP Finsinger F Brodimoprim(Reg.trademark) (RO 10-5970) versus doxycycline in chronic bronchitis. A randomised controlled clinical trial Chemioterapia 1982 157"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0009|cit9","first-page":"345","article-title":"Long-term treatment of bronchiectasis and chronic bronchitis; a controlled study of the effects of tetracycline, penicillin, and an oleandomycin penicillin mixture","volume":"103","author":"Cherniack","year":"1959","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0010|cit10","first-page":"307","article-title":"Prophylactic treatment of chronic bronchitis comparing co-trimoxazole and amoxicillin","volume":"29","author":"Cooper","year":"1975","journal-title":"British Journal of Clinical Practice"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.0954-6820.1964.tb00606.x","article-title":"The relationship of results of sputum cultures to clinical effects in a controlled trial of continuous antibiotic treatment of chronic bronchitis with demethylchlortetracycline or penicillin-v","volume":"175","author":"Djajadiningrat","year":"1964","journal-title":"Acta Medica Scandinavica"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0012|cit12","first-page":"427","article-title":"The relationship between bacteriological and clinical results in patients with chronic bronchitis during long-term therapy with tetracycline and sulfaphenazole","volume":"110","author":"Djajadiningrat","year":"1966","journal-title":"Nederlands Tijdschrift voor Geneeskunde"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0140-6736(57)91597-0","article-title":"Effect of antibiotics on purulent sputum in chronic bronchitis and bronchiectasis","volume":"273","author":"Douglas","year":"1957","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1136\/bmj.2.5103.1010","article-title":"Adult chronic bronchitis: continuous antibiotic therapy","volume":"2","author":"Edwards","year":"1958","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0007-0971(62)80012-6","article-title":"Antibiotic regimens in chronic bronchitis","volume":"56","author":"Fear","year":"1962","journal-title":"British Journal of Diseases of the Chest"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0016|cit16","first-page":"131","article-title":"A comparison of oxytetracycline with doxycycline in the winter chemoprophylaxis of chronic bronchitis","volume":"28","author":"Ferguson","year":"1974","journal-title":"British Journal of Clinical Practice"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/bmj.1.5169.297","article-title":"Chemotherapy in chronic bronchitis. Influence of daily penicillin and tetracycline on exacerbations and their cost","volume":"30","author":"Francis","year":"1960","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0018|cit18","first-page":"117S","article-title":"Comparison between ofloxacin and amoxicillin to prevent infective episodes in COPD","volume":"3","author":"Gaffuri Riva","year":"1990","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0019|cit19","first-page":"357","article-title":"Treatment of chronic bronchitis with azidocillin and co-trimoxazole","volume":"99","author":"Gonschewski","year":"1981","journal-title":"Fortschritte der Medizin"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1378\/chest.52.3.376","article-title":"Continuous suppressive antimicrobial treatment in chronic infected bronchitis during the winter months","volume":"52","author":"Goslings","year":"1967","journal-title":"Diseases of the Chest"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0021|cit21","first-page":"1780","article-title":"Treatment of chronic bronchitis with Supristol and a cotrimoxazole preparation","volume":"73","author":"Knothe","year":"1978","journal-title":"Medizinische Klinik"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0022|cit22","first-page":"412","article-title":"BTA study of amoxicillin and ampicillin in bronchitis","volume":"73","author":"MacKay","year":"1979","journal-title":"British Journal of Diseases of the Chest"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0023|cit23","first-page":"245","article-title":"Clinical experience with pivampicillin in chronic bronchitis. A comparative study of ampicillin and pivampicillin","volume":"55","author":"Maesen","year":"1974","journal-title":"Scandinavian Journal of Respiratory Diseases"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0024|cit24","first-page":"A22","article-title":"One year of weekly azithromycin provides no benefit for indigenous Australians living with COPD in remote Australia [Abstract]","volume":"15","author":"Maguire","year":"2010","journal-title":"Respirology"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0025|cit25","first-page":"224","article-title":"A comparative study of the therapeutic efficacy of azidocillin and doxycycline in chronic recurrent bronchitis","volume":"31","author":"Marcic","year":"1977","journal-title":"Praxis und Klinik der Pneumologie"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0026|cit26","first-page":"123","article-title":"A comparative trial of amoxicillin and oxytetracycline in chronic bronchitis","volume":"212","author":"Molla","year":"1974","journal-title":"Practitioner"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1136\/bmj.2.5162.1277","article-title":"An evaluation of continuous antibiotic therapy in chronic bronchitis","volume":"2","author":"Murdoch","year":"1959","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0028|cit28","unstructured":"NCT03262142 Targeted antibiotics for chronic obstructive pulmonary disease: a randomised multicenter trial investigating if targeted antibiotic therapy can improve the prognosis in COPD patients infected with pseudomonas aeruginosa clinicaltrials.gov\/show\/NCT03262142"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0029|cit29","unstructured":"Trimethoprim-sulphamethoxazole in chronic bronchitis The Practitioner 1969 817 89"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0030|cit30","unstructured":"A further comparative trial of co-trimoxazole in chronic bronchitis The Practitioner 1972 838 40"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0031|cit31","first-page":"26","article-title":"Spiramycin and roxithromycin for the treatment of pneumonia and chronic bronchitis exacerbation","volume":"46","author":"Nonikov","year":"2001","journal-title":"Antibiotics and Chemoterapy"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0032|cit32","first-page":"14","article-title":"Four trials of antibiotics in patients with chronic mucopurulent bronchitis","volume":"Suppl 43","author":"Pines","year":"1967","journal-title":"Postgraduate Medical Journal"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0033|cit33","first-page":"61","article-title":"Controlled comparisons of cephaloridine with penicillin and streptomycin in chronic purulent bronchitis","volume":"Suppl 43","author":"Pines","year":"1967","journal-title":"Postgraduate Medical Journal"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"S706","DOI":"10.1093\/infdis\/128.Supplement_3.S706","article-title":"Trimethoprim-sulfamethoxazole in the treatment and prevention of purulent exacerbations of chronic bronchitis","volume":"Suppl 128","author":"Pines","year":"1973","journal-title":"Journal of Infectious Diseases"},{"issue":"7054","key":"10.1002\/14651858.CD013024.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0140-6736(58)90499-9","article-title":"Novobiocin and tetracycline in chronic bronchitis","volume":"272","author":"Pinto","year":"1958","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0036|cit36","first-page":"2449","article-title":"Amoxicillin and ampicillin in the patient with chronic bronchitis. Comparative study : bacteriological, pharmacological and clinical","volume":"4","author":"Puchelle","year":"1975","journal-title":"La Nouvelle Presse Medicale"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0037|cit37","first-page":"81","article-title":"Propicillin in the treatment of chronic bronchitis","volume":"18","author":"Pugh","year":"1964","journal-title":"British Journal of Clinical Practice"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0038|cit38","first-page":"955","article-title":"Chemoprophylaxis with erythromycin stearate or amoxicillin in patients with chronic bronchitis - effects on cellular and humoral immune functions","volume":"66","author":"Ras","year":"1984","journal-title":"South African Medical Journal"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0039|cit39","first-page":"190","article-title":"Azidocillin in chronic bronchitis. A comparative study with SMZ\/TMP","volume":"28","author":"Schildwachter","year":"1977","journal-title":"Die Medizinische Welt"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0040|cit40","unstructured":"Seemungal TA Wilkinson TM Perera W Hurst J Wedzicha JA Long term macrolide therapy decreases exacerbations in COPD American Thoracic Society International Conference; 2007 May 18-23; San Francisco 2007 [C97]"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0041|cit41","first-page":"21","article-title":"Clinical efficacy of carbapenems in the treatment of destructive pneumonia and chronic purulent bronchitis","volume":"48","author":"Sokolova","year":"2003","journal-title":"Antibiotics and Chemoterapy"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0042|cit42","first-page":"3","article-title":"Prolonged preventive antibiotic therapy of chronic bronchitis","volume":"49","author":"Uberti","year":"1969","journal-title":"Clinica Terapeutica"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0043|cit43","first-page":"281","article-title":"Double-blind comparison of tolerance of minocycline and doxycycline","volume":"41","author":"Verbist","year":"1985","journal-title":"Tijdschrift voor Geneeskunde"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0044|cit44","first-page":"746","article-title":"Sulfhamethoxazole-trimethoprim and ampicillin in the treatment of bronchitis. A comparative investigation employing a double-blind technique","volume":"135","author":"Waagepetersen","year":"1973","journal-title":"Ugeskrift for Laeger"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1620\/tjem.176.25","article-title":"Daily single-dose regimen and alternate-two-week triple-dose\/day regimen of oral ofloxacin for the prophylaxis and control of exacerbations of chronic respiratory tract infections","volume":"176","author":"Watanabe","year":"1995","journal-title":"Tohoku Journal of Experimental Medicine"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0046|cit46","first-page":"944","article-title":"The treatment of chronic bronchitis with trimethoprim-sulphamethoxazole (bactrim) a double-blind trial in comparison with epicillin (spectacillin)","volume":"68","author":"Wegmuller","year":"1979","journal-title":"Schweizerische Rundschau fur Medizin Praxis"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0047|cit47","first-page":"A46","article-title":"Effect of long-term erythromycin in COPD trial (ELECT): Exacerbations and inflammation","volume":"62","author":"Wilkinson","year":"2007","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0048|cit48","unstructured":"Zervos M Breen JD Jorgensen DM Goodrich JM Azithromycin microspheres (AZ-M) are as effective as levofloxacin (LEV) in subjects with moderate to very severe COPD Proceedings of the American Thoracic Society 2006 A121"},{"issue":"2","key":"10.1002\/14651858.CD013024.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7189\/jogh.05-020415","article-title":"Global and regional estimates of COPD prevalence: Systematic review and meta-analysis","volume":"5","author":"Adeloye","year":"2015","journal-title":"Journal of Global Health"},{"issue":"8","key":"10.1002\/14651858.CD013024.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"Albert","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0051|cit51","first-page":"555","article-title":"Lung microbiology and exacerbations in COPD","volume":"7","author":"Beasley","year":"2012","journal-title":"International Journal of COPD"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0052|cit52","unstructured":"Joint Formulary Committee British National Formulary www.medicinescomplete.com\/mc"},{"issue":"9","key":"10.1002\/14651858.CD013024.pub2-BIB0053|cit53","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009157.pub2","article-title":"Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease","author":"Chong","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD013024.pub2-BIB0054|cit54","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002309.pub4","article-title":"Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease","author":"Chong","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD013024.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1378\/chest.06-1610","article-title":"Impact of COPD exacerbations on patient-centred outcomes","volume":"131","author":"Cote","year":"2007","journal-title":"Chest"},{"issue":"10","key":"10.1002\/14651858.CD013024.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/thorax.57.10.847","article-title":"Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease","volume":"57","author":"Donaldson","year":"2008","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.rmed.2013.05.004","article-title":"A meta-analysis on the prophylactic use of macrolide antibiotics for the prevention of disease exacerbations in patients with chronic obstructive pulmonary disease","volume":"107","author":"Donath","year":"2013","journal-title":"Respiratory medicine"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1081\/COPD-200053377","article-title":"Minimally clinically important differences in COPD lung function","volume":"2","author":"Donohue","year":"2005","journal-title":"COPD"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0059|cit59","unstructured":"Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management, and prevention of COPD 2019 goldcopd.org\/gold-reports\/"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0060|cit60","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"issue":"10","key":"10.1002\/14651858.CD013024.pub2-BIB0061|cit61","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009764.pub3","article-title":"Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD)","author":"Herath","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0062|cit62","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"1","key":"10.1002\/14651858.CD013024.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1164\/rccm.200505-704OC","article-title":"Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease","volume":"173","author":"Hurst","year":"2006","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","article-title":"Measurement of health status. Ascertaining the minimal clinically important difference","volume":"10","author":"Jaeschke","year":"1989","journal-title":"Controlled Clinical Trials"},{"issue":"11","key":"10.1002\/14651858.CD013024.pub2-BIB0065|cit65","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013198","article-title":"Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis","author":"Janjua","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1183\/09031936.02.00063702","article-title":"Interpreting thresholds for a clinically significant change in health status in asthma and COPD","volume":"19","author":"Jones","year":"2002","journal-title":"European Respiratory Journal"},{"issue":"1","key":"10.1002\/14651858.CD013024.pub2-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1378\/chest.130.1.133","article-title":"Patient understanding, detection, and experience of COPD exacerbations: an observational, interview-based study","volume":"130","author":"Kessler","year":"2006","journal-title":"Chest"},{"issue":"6","key":"10.1002\/14651858.CD013024.pub2-BIB0068|cit68","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002733.pub3","article-title":"Influenza vaccine for chronic obstructive pulmonary disease (COPD)","author":"Kopsaftis","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD013024.pub2-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"19","DOI":"10.5152\/TurkThoracJ.2017.17035","article-title":"A prospective study of bacteriological etiology in hospitalised acute exacerbation of COPD patients: relationship with lung function and respiratory failure","volume":"19","author":"Kuwal","year":"2018","journal-title":"Turkish Thoracic Journal"},{"issue":"2","key":"10.1002\/14651858.CD013024.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"153-62","DOI":"10.5588\/ijtld.12.0401","article-title":"Systematic review and meta-analysis of prophylactic antibiotics in COPD and\/or chronic bronchitis","volume":"17","author":"Lee","year":"2013","journal-title":"The International Journal of Tuberculosis and Lung Disease"},{"issue":"8","key":"10.1002\/14651858.CD013024.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1579-2129(06)60552-1","article-title":"Bacterial etiology of chronic bronchitis exacerbations treated by primary care physicians","volume":"42","author":"Llor","year":"2006","journal-title":"Archivos de Bronconeumologia"},{"issue":"1","key":"10.1002\/14651858.CD013024.pub2-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/resp.12660","article-title":"Global burden of COPD","volume":"21","author":"L\u00f3pez-Campos","year":"2016","journal-title":"Respirology"},{"issue":"1","key":"10.1002\/14651858.CD013024.pub2-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1378\/chest.14-2434","article-title":"Economic burden of COPD in the presence of co-morbidities","volume":"148","author":"Mannino","year":"2015","journal-title":"Chest"},{"issue":"3","key":"10.1002\/14651858.CD013024.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2147\/COPD.S681","article-title":"Role of macrolide therapy in chronic obstructive pulmonary disease","volume":"3","author":"Martinez","year":"2008","journal-title":"International Journal of COPD"},{"issue":"1","key":"10.1002\/14651858.CD013024.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.rmed.2012.10.024","article-title":"Chronic bronchial infection in COPD. Is there an infective phenotype?","volume":"107","author":"Matkovic","year":"2013","journal-title":"Respiratory Medicine"},{"issue":"2","key":"10.1002\/14651858.CD013024.pub2-BIB0076|cit76","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003793.pub3","article-title":"Pulmonary rehabilitation for chronic obstructive pulmonary disease","author":"McCarthy","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD013024.pub2-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1136\/thx.2003.008730","article-title":"Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study","volume":"59","author":"Miravitlles","year":"2004","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pupt.2014.05.002","article-title":"Antibiotic prophylaxis in COPD: why, when, and for whom?","volume":"32","author":"Miravittles","year":"2015","journal-title":"Pulmonary Pharmacology and Therapeutics"},{"issue":"7","key":"10.1002\/14651858.CD013024.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.3390\/ijms18071344","article-title":"Chronic respiratory infection in patients with chronic obstructive pulmonary disease: what is the role of antibiotics?","volume":"18","author":"Miravitlles","year":"2017","journal-title":"International Journal of Molecular Sciences"},{"issue":"7","key":"10.1002\/14651858.CD013024.pub2-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"issue":"3","key":"10.1002\/14651858.CD013024.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"e0121257","DOI":"10.1371\/journal.pone.0121257","article-title":"Prophylactic use of macrolide antibiotics for the prevention of chronic obstructive pulmonary disease exacerbation: a meta-analysis","volume":"10","author":"Ni","year":"2015","journal-title":"PLOS ONE"},{"issue":"10 Suppl 1","key":"10.1002\/14651858.CD013024.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.amjmed.2006.08.006","article-title":"The impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary disease","volume":"119","author":"Niewoehner","year":"2006","journal-title":"American Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD013024.pub2-BIB0083|cit83","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012620.pub2","article-title":"Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis","author":"Oba","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD013024.pub2-BIB0084|cit84","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005305.pub4","article-title":"Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease","author":"Puhan","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2147\/COPD.S54417","article-title":"COPD management costs according to the frequency of COPD exacerbations in UK primary care","volume":"9","author":"Punekar","year":"2014","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0086|cit86","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"8","key":"10.1002\/14651858.CD013024.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/archinte.165.8.891","article-title":"Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease","volume":"165","author":"Rosell","year":"2005","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1136\/thx.2005.041822","article-title":"COPD exacerbations. 2: Aetiology","volume":"61","author":"Sapey","year":"2006","journal-title":"Thorax"},{"issue":"12","key":"10.1002\/14651858.CD013024.pub2-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2014-006720","article-title":"The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study","volume":"4","author":"Schmidt","year":"2014","journal-title":"BMJ Open"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD013024.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1164\/ajrccm.157.5.9709032","article-title":"Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease","volume":"157","author":"Seemungal","year":"1998","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"2","key":"10.1002\/14651858.CD013024.pub2-BIB0091|cit91","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1513\/pats.2306029","article-title":"Bacteria in exacerbations of chronic obstructive pulmonary disease: phenomenon or epiphenomenon?","volume":"1","author":"Sethi","year":"2004","journal-title":"Proceedings of the American Thoracic Society"},{"issue":"22","key":"10.1002\/14651858.CD013024.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1056\/NEJMra0800353","article-title":"Infection in the pathogenesis and course of chronic obstructive pulmonary disease","volume":"359","author":"Sethi","year":"2008","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0093|cit93","first-page":"A2181","article-title":"Impact of antibiotic exposure on the development of antibiotic resistance in COPD","volume":"187","author":"Thurston","year":"2013","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"4","key":"10.1002\/14651858.CD013024.pub2-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1183\/13993003.01406-2015","article-title":"Lung microbiome dynamics in COPD exacerbations","volume":"47","author":"Wang","year":"2016","journal-title":"European Respiratory Journal"},{"issue":"3","key":"10.1002\/14651858.CD013024.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"1602265","DOI":"10.1183\/13993003.02265-2016","article-title":"Prevention of COPD exacerbations:a European Respiratory Society\/American Thoracic Society guideline","volume":"50","author":"Wedzicha","year":"2017","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0096|cit96","unstructured":"World Health Organization Chronic respiratory diseases: burden of COPD www.who.int\/respiratory\/copd\/burden\/en\/"},{"issue":"3","key":"10.1002\/14651858.CD013024.pub2-BIB0097|cit97","first-page":"289","article-title":"Factors contributing to muscle wasting and dysfunction in COPD patients","volume":"2","author":"W\u00fcst","year":"2007","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"issue":"7","key":"10.1002\/14651858.CD013024.pub2-BIB0098|cit98","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002991.pub3","article-title":"Inhaled corticosteroids for stable chronic obstructive pulmonary disease","author":"Yang","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013024.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000350828","article-title":"Macrolide therapy decreases chronic obstructive pulmonary disease exacerbation: a meta-analysis","volume":"86","author":"Yao","year":"2013","journal-title":"Respiration"},{"issue":"3","key":"10.1002\/14651858.CD013024.pub2-BIB0100|cit100","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002990.pub3","article-title":"Self management for patients with chronic obstructive pulmonary disease","author":"Zwerink","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD013024.pub2-BIB0101|cit101","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013024","article-title":"Head-to-head oral prophylactic antibiotics therapy for chronic obstructive pulmonary disease","author":"Threapleton","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD013024.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T09:02:46Z","timestamp":1687338166000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013024.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Airways Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,5,24]]},"references-count":101,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013024.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,24]]}}}